Biopharmaceutical Company.
H.R.107: to sunset the limit on maximum rebate amount for single source drugs.

H.R.3: Lower Drug Costs Now Act of 2019.

Regulatory and legislative proposals in the Administrations Blueprint.

H.R.2113: Prescription Drug STAR Act / H.R.2296: FAIR Drug Pricing Act.

FY 2020 Continuing Resolution. Education about innovative contracting and value based payments.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX